Comprehensive Cancer Care Demands Exceptional Teamwork, Collaboration and Leaders to Bring It to Life.
Centralizing scientific discovery, advanced research, and clinical care—all for a new therapeutic pathway.
New Fox Chase Clinical Trial Could Help Men With Intermediate-Risk Prostate Cancer Avoid Radical Treatment
Could NanoKnife be the future of prostate cancer care?
A Salvage Treatment Jennifer Was Inspired to Salvage.
A Life-Saving Idea for Bladder Cancer Patients.
Fox Chase Cancer Center Researchers Present Further Data on Potential Bladder-Sparing Treatment
Bladder removal is life-altering. This study examines when and why some patients may not need it.
Dr. Laura Bukavina on the Front Lines of Research and War
Fighting for life everywhere she goes.
A $1.4 Million Grant Looks at Prostate Cancer Through a ‘Neighborhood Lens.’
Where a man is born, lives and works can influence his prostate cancer diagnosis, treatment, and survival. But which factors matter most? And what role do they all play together in how he responds to cancer treatment?
What is the Same and What Has Changed with the Artificial Urinary Sphincter?
The artificial urinary sphincter is an implantable device designed to treat incontinence in prostate cancer survivors. The device has existed for 50 years, and in that time, best practices around its use have undergone several paradigm shifts.
Fox Chase Urology Just Took a Big Leap Forward
A new benign urology team adds gravitas to a renowned cancer department.
Fox Chase Researchers Examine Racial Differences in Treatment and Outcomes of First-Line Therapies for Kidney Cancer
Digging into the "why" of racial disparity in kidney cancer outcomes.
How to Perform Device-Free, Free-Handed Transperineal Prostate Biopsy
Fox Chase Cancer Center’s urologic oncology group shares an educational video that provides instruction on how to perform a device-free, free-handed transperineal prostate biopsy.
Urology Team Continues Focus on Improving Kidney Cancer Surgery Outcomes
Two new collaborative publications focus on treatment decisions for patients with renal masses.
Fox Chase Genitourinary Cancer Physicians Gain National Recognition
Three members of Fox Chase Cancer Center’s Genitourinary Cancer Program – Elizabeth Plimack, MD, MS; Alexander Kutikov, MD, FACS; and Benjamin Miron, MD -- have gained national recognition for their work advancing the care of patients ...
Clinical Nurse Manager, Rebecca Farrell, MSN, RN, Keeps Calm, Carries On Amidst COVID-19 Pandemic
As patient care adapted to the restrictions of the COVID-19 pandemic, Farrell continued to ensure that patients had access to cutting-edge care.
Two Studies Provide Answers on Best Approach to Bladder Cancer Treatment
Evaluating the current standards of care for cystectomy yielded interesting results on when it is most appropriate.
Fox Chase Offers Ureteral Mitomycin Gel for Low-Grade Upper Tract Urothelial Carcinoma
Jelmyto provides an alternative treatment option for low-grade UTUC and may spare some patients from nephrectomy. A recent study of the treatment showed a 58% complete response rate.